Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China

• Yilin Chen,
• Zelin Liu,
• Jing Zou,
• Danyu Wang,
• Wenjuan He,
• Li Meng,
• Fanjun Cheng,
• Yanli Zhang,
• Weiming Li

Affiliations

Yilin Chen

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Zelin Liu

Institute of Hematology,Huazhong University of Science and Technology Union Shenzhen Hospital, Guangdong Medical University, Shenzhen, Guangdong

Jing Zou

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Danyu Wang

Institute of Hematology,Huazhong University of Science and Technology Union Shenzhen Hospital, Guangdong Medical University, Shenzhen, Guangdong

Wenjuan He

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Li Meng

Institute of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Fanjun Cheng

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Yanli Zhang

Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan

Weiming Li

Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei